| 1 | Activation of XBP1s attenuates disease severity in models of proteotoxic Charcot–Marie–Tooth type 1BBrain, 2025, 148, 1978-1993 | 8.4 | 3 | Citations (PDF) |
| 2 | Cervical motion alterations and brain functional connectivity in cervical dystonia | 2.6 | 6 | Citations (PDF) |
| 3 | Niacin ameliorates Charcot-Marie-Tooth 4B1 neuropathy without interfering with nerve regeneration | 3.6 | 0 | Citations (PDF) |
| 4 | Interstitial 6q deletion in a patient presenting with drug-resistant epilepsy and Prader-Willi like phenotype: An electroclinical description with literature review | 2.1 | 1 | Citations (PDF) |
| 5 | Intraoperative neurophysiologic monitoring in thoracoabdominal aortic aneurysm surgery can provide real-time feedback for strategic decision making | 2.2 | 13 | Citations (PDF) |
| 6 | Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access | 62.3 | 249 | Citations (PDF) |
| 7 | ADAM17 Regulates p75NTR-Mediated Fibrinolysis and Nerve Remyelination | 3.7 | 12 | Citations (PDF) |
| 8 | Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis | 3.5 | 49 | Citations (PDF) |
| 9 | Treatment with IFB-088 Improves Neuropathy in CMT1A and CMT1B Mice | 3.7 | 37 | Citations (PDF) |
| 10 | Guillain‐Barré syndrome and COVID‐19: A 1‐year observational multicenter study | 3.5 | 33 | Citations (PDF) |
| 11 | A novel mouse model of CMT1B identifies hyperglycosylation as a new pathogenetic mechanism | 2.9 | 12 | Citations (PDF) |
| 12 | Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions | 6.3 | 165 | Citations (PDF) |
| 13 | Dysregulation of myelin synthesis and actomyosin function underlies aberrant myelin in CMT4B1 neuropathy | 7.5 | 26 | Citations (PDF) |
| 14 | Electrophysiological features of acute inflammatory demyelinating polyneuropathy associated with SARS-CoV-2 infection | 2.2 | 20 | Citations (PDF) |
| 15 | Metachromatic leukodystrophy: A single‐center longitudinal study of 45 patients | 3.2 | 59 | Citations (PDF) |
| 16 | Surgical and Radiologic Prognostic Factors in Intramedullary Spinal Cord Lesions | 1.5 | 1 | Citations (PDF) |
| 17 | Sensory trick phenomenon in cervical dystonia: a functional MRI study | 3.4 | 36 | Citations (PDF) |
| 18 | Phosphorylation of eIF2α Promotes Schwann Cell Differentiation and Myelination in CMT1B Mice with Activated UPR | 3.7 | 21 | Citations (PDF) |
| 19 | Serum phosphorylated neurofilament heavy-chain levels reflect phenotypic heterogeneity and are an independent predictor of survival in motor neuron disease | 3.4 | 32 | Citations (PDF) |
| 20 | Botulinum toxin for the management of spasticity in multiple sclerosis: the Italian botulinum toxin network study | 1.7 | 14 | Citations (PDF) |
| 21 | Schwann cells ER-associated degradation contributes to myelin maintenance in adult nerves and limits demyelination in CMT1B mice | 3.2 | 22 | Citations (PDF) |
| 22 | Enhanced axonal neuregulin-1 type-III signaling ameliorates neurophysiology and hypomyelination in a Charcot–Marie–Tooth type 1B mouse model | 2.9 | 35 | Citations (PDF) |
| 23 | Two factor-based reprogramming of rodent and human fibroblasts into Schwann cells | 13.7 | 35 | Citations (PDF) |
| 24 | Rituximab in refractory chronic inflammatory demyelinating polyradiculoneuropathy: report of four cases | 3.4 | 26 | Citations (PDF) |
| 25 | Perk
Ablation Ameliorates Myelination in S63del-Charcot–Marie–Tooth 1B Neuropathy | 3.4 | 23 | Citations (PDF) |
| 26 | Refractory chronic migraine: is drug withdrawal necessary before starting a therapy with onabotulinum toxin type A? | 1.7 | 18 | Citations (PDF) |
| 27 | Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial | 62.3 | 472 | Citations (PDF) |
| 28 | Combined gene/cell therapies provide long-term and pervasive rescue of multiple pathological symptoms in a murine model of globoid cell leukodystrophy | 2.9 | 67 | Citations (PDF) |
| 29 | Down-sizing of neuronal network activity and density of presynaptic terminals by pathological acidosis are efficiently prevented by Diminazene Aceturate | 4.5 | 32 | Citations (PDF) |
| 30 | Loss of Fig4 in both Schwann cells and motor neurons contributes to CMT4J neuropathy | 2.9 | 45 | Citations (PDF) |
| 31 | Sativex® and clinical–neurophysiological measures of spasticity in progressive multiple sclerosis | 3.4 | 54 | Citations (PDF) |
| 32 | Defining Peripheral Nervous System Dysfunction in the SOD-1G93ATransgenic Rat Model of Amyotrophic Lateral Sclerosis | 1.8 | 20 | Citations (PDF) |
| 33 | Jab1 regulates Schwann cell proliferation and axonal sorting through p27 | 9.2 | 41 | Citations (PDF) |
| 34 | Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis? | 3.9 | 72 | Citations (PDF) |
| 35 | Quantitative EMG of external urethral sphincter in neurologically healthy men with prostate pathology | 2.2 | 3 | Citations (PDF) |
| 36 | Persistent acidosis affects electrophysiological transmission and synaptic homeostasis of neuronal networks | 2.3 | 0 | Citations (PDF) |
| 37 | Peripheral nerve morphogenesis induced by scaffold micropatterning | 12.1 | 44 | Citations (PDF) |
| 38 | Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy | 36.2 | 1,098 | Citations (PDF) |
| 39 | Resetting translational homeostasis restores myelination in Charcot-Marie-Tooth disease type 1B mice | 9.2 | 137 | Citations (PDF) |
| 40 | Schwann cell‐specific JAM‐C‐deficient mice reveal novel expression and functions for JAM‐C in peripheral nerves | 0.6 | 20 | Citations (PDF) |
| 41 | Practice of yoga may cause damage of both sciatic nerves: a case report | 1.7 | 19 | Citations (PDF) |
| 42 | Urokinase Plasminogen Receptor and the Fibrinolytic Complex Play a Role in Nerve Repair after Nerve Crush in Mice, and in Human Neuropathies | 2.3 | 16 | Citations (PDF) |
| 43 | Compensatory movement-related recruitment in amyotrophic lateral sclerosis patients with dominant upper motor neuron signs: An EEG source analysis study | 2.5 | 15 | Citations (PDF) |
| 44 | A fatal case of Churg–Strauss syndrome presenting with acute polyneuropathy mimicking Guillain–Barré syndrome | 1.7 | 11 | Citations (PDF) |
| 45 | Computational classifiers for predicting the short-term course of Multiple sclerosis | 1.9 | 52 | Citations (PDF) |
| 46 | Gene therapy augments the efficacy of hematopoietic cell transplantation and fully corrects mucopolysaccharidosis type I phenotype in the mouse modelBlood, 2010, 116, 5130-5139 | 4.2 | 169 | Citations (PDF) |
| 47 | Quantitative Sensory Testing of Peripheral Thresholds in Patients with Lifelong Premature Ejaculation: A Case-Controlled Study | 0.5 | 33 | Citations (PDF) |
| 48 | Acceptance of and Discontinuation Rate from Paroxetine Treatment in Patients with Lifelong Premature Ejaculation | 0.5 | 46 | Citations (PDF) |
| 49 | Human neural stem cells ameliorate autoimmune encephalomyelitis in non‐human primates | 6.6 | 208 | Citations (PDF) |
| 50 | Electrospun micro- and nanofiber tubes for functional nervous regeneration in sciatic nerve transections | 2.9 | 292 | Citations (PDF) |
| 51 | Ablation of the UPR-Mediator CHOP Restores Motor Function and Reduces Demyelination in Charcot-Marie-Tooth 1B Mice | 11.0 | 262 | Citations (PDF) |
| 52 | Motor evoked potentials in a mouse model of chronic multiple sclerosis | 2.2 | 28 | Citations (PDF) |
| 53 | Loss of glial fibrillary acidic protein (GFAP) impairs Schwann cell proliferation and delays nerve regeneration after damage | 2.4 | 186 | Citations (PDF) |
| 54 | Oligodendroglial Progenitor Cell Therapy Limits Central Neurological Deficits in Mice with Metachromatic Leukodystrophy | 3.7 | 63 | Citations (PDF) |
| 55 | Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice | 10.6 | 217 | Citations (PDF) |
| 56 | Comparison of the Effect of Sildenafil and Apomorphine SL on Nocturnal Erections in Healthy Volunteers: A Placebo-Controlled Study | 2.1 | 5 | Citations (PDF) |
| 57 | Both Laminin and Schwann Cell Dystroglycan Are Necessary for Proper Clustering of Sodium Channels at Nodes of Ranvier | 3.7 | 107 | Citations (PDF) |
| 58 | Loss of Mtmr2 Phosphatase in Schwann Cells But Not in Motor Neurons Causes Charcot-Marie-Tooth Type 4B1 Neuropathy with Myelin Outfoldings | 3.7 | 98 | Citations (PDF) |
| 59 | Disruption of Mtmr2 produces CMT4B1-like neuropathy with myelin outfolding and impaired spermatogenesis | 5.4 | 178 | Citations (PDF) |
| 60 | Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells | 10.6 | 117 | Citations (PDF) |
| 61 | Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells | 10.6 | 278 | Citations (PDF) |
| 62 | Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis | 37.9 | 1,078 | Citations (PDF) |
| 63 | Effects of atidarsagene autotemcel gene therapy on peripheral nerves in late-infantile metachromatic leukodystrophy | 8.4 | 2 | Citations (PDF) |
